Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits

Ítems similars

• Risk factors determining the need for second-look endoscopy for peptic ulcer bleeding after endoscopic hemostasis and proton pump inhibitor infusion
  per: Cheng, Hsiu-Chi, et al.
  Publicat: (2016)
• Role of proton pump inhibitors in the management of peptic ulcer bleeding
  per: Lin, Hwai-Jeng
  Publicat: (2010)
• Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection
  per: Tsai, Jai-Jen, et al.
  Publicat: (2009)
• High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
  per: Hsieh, Yu-Hsi, et al.
  Publicat: (2013)
• Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
  per: Yen, Hsu-Heng, et al.
  Publicat: (2012)